Interventions for Tuberculosis Control and Elimination 2002

631. Weis SE, Slocum PC, Blais FX, King B, Nunn M, Matney GB, Gomez E,
Foresman BH. The effect of directly observed therapy on the rates of drug resistance
and relapse in tuberculosis. N Engl J Med 1994; 330: 1179-84.
632. Trébucq A, Anagonou S, Gninafon M, Lambregts K, Boulahbal F. Prevalence
of primary and acquired resistance of Mycobacterium tuberculosis to antituberculosis
drugs in Benin after 12 years of short-course chemotherapy.
Lung Dis 1999; 3: 466-70.
Int J Tuberc
633. Kenyon TA, Mwasekaga MJ, Huebner R, Rumisha D, Binkin N, Maganu E.
Low levels of drug resistance amidst rapidly increasing tuberculosis and human
immunodeficiency virus co-epidemics in Botswana.
3: 4-11.
Int J Tuberc Lung Dis 1999;
634. Snider DE, Jr., Kelly GD, Cauthen GM, Thompson NJ, Kilburn JO. Infection
and disease among contacts of tuberculosis cases with drug-resistant and drugsusceptible
bacilli. Am Rev Respir Dis 1985; 132: 125-32.
635. Teixeira L, Perkins MD, Johnson JL, Palaci M, do Valle Dettoni V, Canedo
Rocha LM, Debanne S, Talbot E, Dietze R. Infection and disease among household
contacts of patients with multidrug-resistant tuberculosis.
Dis 2001; 5: 321-8.
Int J Tuberc Lung
636. Wilson TM, De Lisle GW, Collins DM. Effect of inhA and katG on isoniazid resistance
and virulence of Mycobacterium bovis. Mol Microbiol 1995; 15: 1009-15.
637. Manca D, Paul S, Barry CE, III, Freedman VH, Kaplan G. Mycobacterium tuberculosis
catalase and peroxidase activities and resistance to oxidative killing in
human monocytes in vitro. Infect Immun 1999; 67: 74-9.
638. van Soolingen D, De Haas PEW, van Doorn HR, Kuijper E, Rinder H,
Borgdorff MW. Mutations at amino acid position 315 of the katG gene are associated
with high-level resistance to isoniazid, other drug resistance, and successful
transmission of Mycobacterium tuberculosis in The Netherlands.
2000; 182: 1788-90.
J Infect Dis
639. Hong YP, Kim SJ, Bai JY, Lew WJ, Lee EG. Twenty-year trend of chronic
excretors of tubercle bacilli based on the nationwide tuberculosis prevalence surveys
in Korea, 1975-1995. Int J Tuberc Lung Dis 2000; 4: 911-9.
640. Boulahbal F, Khaled S, Tazir M. The interest of follow-up of resistance of the
tubercle bacillus in the evaluation of a programme.
Dis 1989; 64: 23-5.
Bull Int Union Tuberc Lung
641. Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis. A general
review. Adv Tuberc Res 1969; 17: 28-106.
642. Singh J, Garg PK, Tandon RK. Hepatotoxicity due to antituberculosis therapy.
Clinical profile and reintroduction of therapy.
211-4.
J Clin Gastroenterol 1996; 22:
643. Pech O, May A, Henrich R, Mayer G. Orale Schnelldesensibilisierung mit
Rifampicin. Deutsch Med Wschr 2001; 126: 16.
212